Armour's Gammar IV human immune globulin
Executive Summary
FDA approves the intravenous immune globulin for patients with primary immune deficiency. Gammar IV is "used to replace or boost immunoglobulin IgG," Armour said in an April 24 release. A number of firms market human immune globulin products.